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To the Editor,
In psoriasis, a chronic inflammatory skin disease with a complex pathophysiology, multiple epidermal differentiation and immune-related genes interact with environmental factors [1] . Despite recent findings on pathogenic related-immune cellular subsets and cytokines (e.g. Th17 and Th22 pathways), the ultimate factors that trigger and preserve inflammation remain unknown. TLRs are germ line-encoded pattern-recognition receptors that recognize pathogen-associated and molecular patterns (PAMPs) and tissue damage-associated molecular patterns (DAMPs) such as self-nucleic acids. These receptors, expressed by immune and nonprofessional immune cells (i.e. keratinocytes), constitute a main immune sensing system that induces rapid inflammatory responses. Abnormal TLR function is related to chronic inflammatory and autoimmune diseases [2] . In psoriasis, TLRs are involved in i) triggering psoriasis-related cytokine secretion on keratinocytes after PAMP/DAMP-induced activation, ii) dendritic cell (DC) activation elicited by self-DNA-LL-37 complexes via TLR7, TLR8 and TLR9, breaking immune-tolerance [3] , and iii) IL-23/Th17 axis promotion inducing IL-23 production in DCs and macrophages [4] .
To explore the role of TLRs in psoriasis, we analysed 11 single nucleotide polymorphisms (SNPs) (Table 1) in 304 Spanish psoriasis patients and 305 healthy controls. Inclusion criteria were age !18 years and a follow-up of !6 months. The ethics committee approved the study protocol and all patients gave written informed consent before inclusion and blood extraction for TLR genotyping. Patients who received !1 systemic treatment, biological agents or phototherapy, were included in the moderate-to-severe group, according to previous studies [5] . The age at disease onset was dichotomized as <40 years (early-onset psoriasis) vs. !40 years (late onset psoriasis), a cut-off used in previous studies [6] . Table 1 shows the clinical and demographic characteristics of the study population. Clinical features were compared according to psoriasis severity. Genetic data analysis showed all SNPs analysed were in HWE (p > 0.05) except TLR9 rs5743836, which was in disequilibrium only in the patient group (p = 0.02), suggesting a possible association with psoriasis. Linkage disequilibrium (LD) analysis was made between SNPs of the same gene and found high LD between TLR3, TLR4 and TLR9 SNPs. We investigated whether any TLR SNP studied acted as a psoriasis susceptibility genetic factor by comparing genetic data of psoriasis patients and controls. There were significant differences for TLR9 rs5743836; specifically, the homozygous CC genotype was more frequent in patients (2.3% vs. 0%; p = 0.0278), in agreement with the disequilibrium observed in the HWE analysis and suggesting a potential association between the CC genotype and psoriasis ( Table 2) .
Potential associations between allelic and genotypic frequencies of all TLR SNPs and psoriasis severity, the presence of PsA and age at disease onset were assessed. Only TLR7 rs179008 showed a trend to greater disease severity (p = 0.0440) but was not significant in the multivariate analysis. The T allele and the pooled AT + TT genotype of TLR7 rs179008 SNP were significantly associated with PsA in the univariate analysis and multivariate analyses adjusted for sex, age at disease onset, disease duration, family history and PASI values (p = 0.0121 and p = 0.0344, respectively) ( Table 2 ). According to age of disease onset, significant associations were found between the TLR3 rs3775291 polymorphism and early-onset psoriasis ( Table 2 ). Heterozygous genotypes of TLR9 rs187084 and rs352140 SNPs were significantly associated with early-onset psoriasis in a dominant inheritance pattern (p = 0.0067 and p = 0.0346, respectively) ( Table 2) . Despite the high LD between TLR9 SNPs, haplotype analysis showed no relevant results.
We examined TLR polymorphisms as susceptibility and diseasemodifying genetic factors in psoriasis. Few recent articles have investigated this issue [7] [8] [9] [9] . We expanded the analysis to multiple SNPs of many relevant TLRs, specifically including SNPs of intracellular nucleic acid-sensing TLRs (TLR3, TLR7 and TLR9) believed to play a key role in psoriasis, and the most-studied cellsurface TLRs (TLR2 and TLR4). We found no relevant role for the TLR2 and TLR4 SNPs studied in psoriasis susceptibility, in contrast to previous reports [[ 5 5 _ T D $ D I F F ] [ 2 7 _ T D $ D I F F ] 7-9], [7] [8] [9] . Genetic differences in the populations studied might explain the contradictory results [7] [8] [9] . We also found a significant association between the TLR9 rs5743836 polymorphism and psoriasis. Surprisingly, Zablotna et al. linked TLR9 rs5743836 with a more severe and earlier psoriasis onset [9] . To our knowledge, this is the first study linking TLR9 rs5743836 SNP to psoriasis susceptibility.
As a disease-modifying genetic factor, the hypomorphic TLR7 rs179008 polymorphism was significantly associated with psoriasis severity, but not in the multivariate analysis. However, it was significantly associated with PsA, despite a very high confounding variable adjustment. Although TLR7 is known to play a role in DC activation, which drives the inflammatory cascade in psoriasis, no specific role has been postulated in PsA, as it has in rheumatoid arthritis [10] . The most notable findings were regarding the age at onset of psoriasis. First, there was an association between TLR3 rs3775291 and early-onset psoriasis in the univariate and multivariate analyses. This SNP has been related to a hypomorphic form that down-regulates receptor inflammatory activity although how it contributes to an earlier onset of psoriasis is not clear and is beyond the scope of this work. Secondly, the mutated alleles of the TLR9 rs187084 and rs352140 polymorphisms were associated with early-onset psoriasis in a dominant pattern of inheritance. Zablotna et al. observed a significant association between the TLR9 rs5743836 polymorphism and more severe and earlier disease onset. These three mutated alleles of TLR9 have been shown to up-regulate receptor transcription activity.
Bearing in mind the role of the TLR9 rs5743836 polymorphism as a genetic risk factor for psoriasis and the association between early-onset psoriasis and a more severe phenotype, our results seem to fit well in a multiple relationship where greater TLR9 transcription activity leads to earlier disease onset, a more severe phenotype and a greater risk for psoriasis.
In conclusion, our results strengthen the concept that acid nucleic-sensing TLRs play a key role in psoriasis and showed significant associations between functional TLR3, TLR7 and TLR9 SNPs and PsA, earlier disease onset and a greater risk for psoriasis. 
Letter to the Editor

A novel vitamin D receptor polymorphism associated with leprosy
Letter to the Editor Leprosy is a chronic infectious disease that primarily affects peripheral nerves, and the skin, but can also compromise functions of the eyes and other organs. Mycobacterium leprae (M. leprae) is the etiological agent and an obligate intracellular parasite [1] . Leprosy remains a serious public health problem in developing countries, such as India, Brazil and Indonesia, and it is endemic in Africa, Asia and Latin America [2] .
Clinically, leprosy is a spectral disease presenting the tuberculoid pole with cell-mediated response and the lepromatous form, often with Th2 response. There is also a transition group between both forms, denominated as borderline. The World Health Organization (WHO) guidelines classify leprosy patients into two categories: Paucibacillary (PB), which includes tuberculoid leprosy and some borderline tuberculoid leprosy; and Multibacillary (MB), which includes a borderline group (borderline tuberculoid, mid borderline, borderline lepromatous) and lepromatous leprosy [3] .
Several aspects related to host, pathogen and environment contribute to maintain epidemiological rates. Individual genetic susceptibility is a determining factor, and various genes and their polymorphisms have been linked to or associated with susceptibility to leprosy including the Vitamin D receptor (VDR) [4] . This receptor has several single nucleotide polymorphisms (SNPs) located in restriction sites near the 3 0 UTR region. The TaqI (rs731236, also known as T61968C) is a synonymous variation (located at +352 position of exon 9) that does not alter the amino acid sequence, but affects the stability of mRNA, altering protein expression [5] . Therefore, it is reasonable to hypothesize that VDR polymorphisms may play a critical role in leprosy.
A previous study reported interaction between the VDR T61968C polymorphism and leprosy susceptibility in a Brazilian population [6] . Here, we tested for differences in genetic variations between 132 patients with a diagnosis of leprosy (63 PB and 69 MB) and 138 household contacts (HC) to identify susceptibility and make predictions regarding development of leprosy. Genotyping analysis of T61968C (NCBI: #AY342401) polymorphism was performed through PCR-RFLP, and we have described, for the first time, the A61894G (NCBI: #AY427834) polymorphism (also in the 3 0 UTR region), evaluated through LIS-SSCP. Genotypes were also compared using a Mitsuda test for each patient, and the polymorphisms were confirmed by sequencing. Statistical analyses were performed using R (2017, R Foundation for Statistical Computing, Vienna, Austria) and BioEstat 5.0 software. Significant differences for allele frequency, association of the VDR genotypes with age and Mitsuda and Hardy-Weinberg equilibrium (HWE) values were tested using Chi-square. Leprosy outcome was predicted through odds ratio (OR). P < .05 was considered significant.
In our cohort study, samples were randomly selected. The disease affected both sexes, however it is more incident in males, as demonstrated previously [7] . Moreover, genetic polymorphisms can vary depending on the population [8] . Our study was performed in a miscegenated population, and our results may be a molecular signature in a high endemic country.
Our analysis revealed that A61894G in PB patients is under selection (P = .004), and the mutant allele may still be incorporated in this group (Table 1 ). There was a significant different for A61894G polymorphism genotypes between HC and PB groups (P = .047). In (GG + AG)x(AA) analysis comparing HC and PB, the G allele was significantly more frequent in the HC group (P = .037). Age, Mitsuda value and gender were not correlated to genetic variations.
For OR analysis, the Mitsuda values were transformed into qualitative data (Table 2) as previously described [9] . Combined tests of T61968C and Mitsuda values among patients and HC showed that patients with a 'TT' genotype and negative Mitsuda response were 5.23 times more chance (OR = 5.23; CI95%:2.25-12.16; P = 0.0002) to develop leprosy. This profile was also verified for the T allele in (TT + TC) analysis (OR = 2.25; CI95%:1.32-3.85; P = 0.004). Polymorphisms in VDR, an immune response gene, may influence intracellular growth of mycobacterium. Variations in T61968C and A61894G may alter mRNA stability leading to an imbalance of Th1 to Th2 cytokines, which predicts clinical evolution of leprosy in patients. Considering the importance of Mitsuda values to predict immunological responses, we suggest that the chance of leprosy occurrence is highly related to this test, and patients with negative Mitsuda responses have a higher risk of developing leprosy, which is also previously confirmed [9] .
